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Curricular priorities for business ethics in medical
practice and research: recommendations from
Delphi consensus panels
James M DuBois1*, Elena M Kraus2, Kamal Gursahani3, Anthony Mikulec4 and Erin Bakanas5
Abstract
Background: No published curricula in the area of medical business ethics exist. This is surprising given that
physicians wrestle daily with business decisions and that professional associations, the Institute of Medicine, Health
and Human Services, Congress, and industry have issued related guidelines over the past 5 years. To fill this gap,
the authors aimed (1) to identify the full range of medical business ethics topics that experts consider important to
teach, and (2) to establish curricular priorities through expert consensus.
Methods: In spring 2012, the authors conducted an online Delphi survey with two heterogeneous panels of
experts recruited in the United States. One panel focused on business ethics in medical practice (n = 14), and 1
focused on business ethics in medical research (n = 12).
Results: Panel 1 generated an initial list of 14 major topics related to business ethics in medical practice, and
subsequently rated 6 topics as very important or essential to teach. Panel 2 generated an initial list of 10 major
topics related to business ethics in medical research, and subsequently rated 5 as very important or essential. In
both domains, the panel strongly recommended addressing problems that conflicts of interest can cause, legal
guidelines, and the goals or ideals of the profession.
Conclusions: The Bander Center for Medical Business Ethics at Saint Louis University will use the results of the
Delphi panel to develop online curricular resources for each of the highest rated topics.
Keywords: Medical business ethics, Professional ethics, Clinical ethics, Medical ethics, Medical education, Graduate
medical education, Business in medicine, Healthcare industry, Delphi consensus
Background
A recent Institute of Medicine report estimates that annu-
ally up to 30% ($765 billion) of health care costs are po-
tentially avoidable: nearly $210 billion may be attributable
to unnecessary services provided by physicians and $55
billion attributable to missed prevention opportunities [1].
Against this background, the Alliance for Academic In-
ternal Medicine and the American College of Physicians
collaborated in producing a curriculum for residents fo-
cused on incorporating high-value, cost-conscious care
principles into their clinical practice [2]. The development
of this curriculum can be seen as part of a larger
movement within academic medical centers to educate phy-
sicians about the business dimension of medicine. Several
model curricula have been published over the past 5 years
addressing a wide variety of topics [2-6]. Nevertheless, pre-
liminary research reveals that, while conflicts of interest are
sometimes addressed, there are no proposed curricula in the
larger topic of medical business ethics, which we define as
the ethical engagement of the financial dimension of med-
ical practice and research. Many important topics such as
Medicare fraud and abuse are not uniformly presented to
training physicians in the United States [6].
This is surprising for several reasons. First, financially
motivated violations of professional ethics in medical
practice and research have received growing attention in
the media, including the performance of unnecessary
surgeries with the aim of increasing income, upcoding,
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and conducting research without adequately disclosing
industry sponsorship [7-10]. Preserving trust in the insti-
tution of medicine will require interventions to protect
medical professionalism in an increasingly complex busi-
ness environment. Second, over the past 5 years, profes-
sional associations [11,12], the Institute of Medicine [13],
the Department of Health and Human Services [14],
Congress [15], and the pharmaceutical industry [16],
have issued new guidelines and requirements address-
ing financial conflicts of interest in medical practice
and research. It will be important to update the curric-
ula of medical ethics and professionalism training pro-
grams to incorporate information about these evolving
standards and requirements. Third, the Accreditation
Council for Graduate Medical Education (ACGME) lists
both professionalism (which includes “an adherence to
ethical principles”) and systems-based practice (which
includes “an awareness of the larger context and system
of health care”) as two of their 6 core competencies of
patient care [17]. Moreover, medical students and resi-
dents support initiatives in ethics and professionalism
educational initiatives [18]. Nevertheless, while courses
in medical ethics have been an established part of the
medical curriculum for more than a decade [19,20],
these courses have traditionally focused on matters of
clinical ethics with limited regard for the impact finan-
cial factors can have on clinical care. Finally, physicians
struggle with questions of business ethics on a day-to-
day basis as they decide whether to use newer more
expensive treatments, respond to demands from hos-
pital administrators and practice managers, collaborate
with device representatives, or decide whether to en-
roll a patient in a clinical trial [21,22].
The Bander Center for Medical Business Ethics was
established at Saint Louis University with an endowment
gift from the BF Charitable Foundation in 2007 with the
mission of promoting ethical business practices in med-
ical care and research through the development of train-
ing and investigation opportunities for medical students,
residents and physicians in practice. Consistent with this
mission, Bander Center-affiliated faculty and staff collab-
orated in conducting a Delphi consensus panel project
to establish priorities for curricula in business ethics in
medical practice and research. Delphi panels are used
with the purpose of establishing a consensus on topics
such as health care quality indicators [23], policy prior-
ities [24], or educational curricula [25]. Often the purpose
is to establish priorities in the face of an overwhelming
number of options (such as quality indicators or curricular
topics). However, given the relative lack of any guidance
on developing curricula in medical business ethics, our
Delphi project had two aims: (a) to identify the full range
of medical business ethics topics that experts generally
consider important to teach (that is, to sketch the
landscape of medical business ethics); and (b) to estab-
lish curricular priorities through expert consensus.
Methods
Project design and panelists
Two national Delphi consensus panels were conducted by
the Bander Center for Medical Business Ethics at Saint
Louis University using online surveys hosted in Qualtrics,
which is an online survey software system that is HIPAA
compliant. (The software system is available from
Qualtrics LLC, Provo, UT through www.qualtrics.com,
site accessed August 13, 2014.) Participants accessed the
survey through unique links, and survey administrators
accessed data via a password protected website. Participa-
tion was identifiable only to the survey administrators (the
first two authors), which enabled us to follow up with tar-
geted reminders across both rounds of the survey.
Delphi panels are typically conducted using surveys to
enable anonymous, individual responses, which prevents
groupthink [26]. Delphi panels begin by posing an open-
ended question (round 1); the project team then collates
and analyzes round 1 responses to produce clear lists of
items. In round 2, the project team presents panelists
with refined responses from round 1, asking them to
rate items using a Likert-type scale. “Consensus” may be
defined in a variety of ways, either by requiring a major-
ity or super-majority of respondents to score an item as
high-priority or by using a mean score as a cut off point.
A third round may be used to refine answers when new
information is required [27].
Our purpose in using a Delphi survey was not to pro-
duce generalizable knowledge, but rather to identify con-
sensus among experts. Accordingly, panelists were selected
using purposive, non-probability sampling. Delphi panels
typically include experts in a field [26,27]. We aimed to re-
cruit heterogeneous experts on our panels for two reasons.
First, panels that include diverse stakeholders—such as
physicians in training, physicians in practice, researchers,
administrators, and government oversight personnel—
enjoy increased credibility and acceptance [23]. Second,
because business ethics in medical research and practice is
such a young area of investigation, few well-rounded ex-
perts exist. It is therefore necessary to recruit people with
diverse areas of specialization in order to represent the full
range of issues in medical business ethics.
Panelists were identified through searches of PubMed
and Google using relevant keywords such as “medical
business ethics, “conflicts of interest,” “ethics and fraud,”
as well as personal contacts of team members, who have
actively studied medical business ethics as fellows, staff,
or faculty within the Bander Center for Medical Business
Ethics at Saint Louis University. Panelists received an
email invitation that provided details on the topic, process,
and time commitment. Additionally, one member of the
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authorship team participated on each panel (DuBois on
the research panel, and Bakanas on the practice panel).
This enabled each of the two authors to contribute topics
to the first round based on their literature reviews and
general expertise; however, the potential to bias outcomes
was limited by three facts: On each panel 92% or more of
the panelists were not authors, each panelist provided re-
sponses independently, and panelists were blind to iden-
tity of other panelists.
Panel 1 addressed curricular priorities for education on
business ethics in medical practice. Panelists are listed in
(Additional file 1), and included individuals with expertise in
medical practice, medical education, medical ethics, medical
sociology, health care administration, health economics,
health law, outcomes research, and government over-
sight. The panel had 14 experts; 12 participated in both
rounds.
Panel 2 addressed business ethics in medical research.
Panelists are listed in (Additional file 2) and included indi-
viduals with expertise in medical research, research train-
ing, research ethics, social science, research administration,
health economics, research regulations, and government
oversight. Panel 2 had 12 experts; 10 participated in both
rounds. Both participation rates across the two rounds
are excellent [26]. Round 1 began in spring 2012;
round 2 began in summer 2012 and closed in August.
A description of the consensus-building project was
provided to the Institutional Review Board (IRB) at Saint
Louis University. The corresponding author received a
determination letter from the IRB stating that the pro-
ject did not constitute research because its purpose was
to generate a consensus rather than generalizable know-
ledge. However, all participants freely consented to par-
ticipate in the panel and provided permission to publish
their names and biographical details, which they reviewed
and approved.
Survey prompts and response analysis
In Round 1 participants responded to the following
prompt:
Please list up to 10 topics that you consider most im-
portant to address within educational programs for
physicians-in-training in the domain of business ethics
in medical practice [panel 1]/research [panel 2].
[For panel 1] Your topics may pertain to matters of
law, reimbursement, ethics, professionalism, and any
other issues you find most relevant.
[For panel 2] Your topics may pertain to matters of
law, research funding, ethics, professionalism, and
other matters you find most relevant.
To prepare items for Round 2, the project team: (1)
collated all Round 1 responses; (2) eliminated responses
that were unclear (such as Program Integrity), unrelated
to business ethics (such as Euthanasia in Europe or
Genetic Testing), or redundant; and (3) identified major
subject headings and subsumed specific topics under them.
In Round 2 the project team presented panelists
with each distinct major topic with 2 – 3 examples of
subtopics that might be addressed within educational
sessions. Panelists were asked to rate separately how
important they think it is to teach each of the topics to
medical students and to residents: (1) not at all important;
(2) somewhat important; (3) important; (4) very import-
ant; or (5) essential.
We defined a consensus on the importance of teaching
a topic as receiving a score of 4 (very important) or 5
(essential) from a simple majority of panelists. Some-
times a higher threshold is used to define a consensus
(such as a super majority of 70% or higher); but the re-
search team deemed this inappropriate as most experts
on our panel had expertise on only some topics relevant
to medical business ethics.
Results
Results from Panel 1: business ethics in medical practice
In response to our initial open-ended prompt, panel 1
produced 103 total responses. The project team reduced
these to 14 distinct major topics, each with 2 – 3 subtopics.
Table 1 presents all 14 topics from round 1.
A majority of panelists rated 6 topics as very import-
ant or essential to teach to medical students and resi-
dents: (1) problems that can arise from conflicts of
interest; (2) general healthcare organization and systems;
(3) fostering patient care quality and safety; (4) medical
professionalism, the goals of medicine, and their relation-
ship to medical ethics; (5) the structure of and ethical is-
sues surrounding reimbursement systems for physicians;
and (6) the legal framework for the business of medicine.
Table 1 presents these topics rank ordered using the mean
medical student (MS) curriculum importance score; it also
presents subtopics within each of these categories. Two
additional topics received a majority rating of 4 or 5 for
residents or post-graduates (PGs): (6) conflicts of interest
arising from physician relationships with pharmaceutical
and device industries; and (8) good stewardship and re-
source utilization. The remaining topics received a mean
rating of less than 4 for both educational groups and failed
to achieve a consensus for either group.
Results from Panel 2: business ethics in medical research
Panel 2 generated 97 total responses. These were reduced
to 10 distinct major topics, each with 2 – 3 subtopics.
Table 2 presents the 10 topics from round 1.
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Problems that can arise from conflicts of interest YES (10/12) 4.4 YES (9/12) 4.6
- Biased prescribing, advising on formularies, or selection of devices
- Harm to patient trust
- Bias operates unconsciously and unintentionally, making it difficult
to manage
General healthcare organization and systems YES (8/12) 4.1 YES (11/12) 4.4
- Medicaid/Medicare and private insurance industry
- Drivers of cost increases, gaps in system, and other challenges
- Alternative models, including international models
Fostering patient care quality and safety YES (9/12) 4.1 YES (10/12) 4.3
The cost of medical errors
- Strategies for improving patient care quality
- Strategies for addressing medical errors
Medical professionalism, the goals of medicine, and their relationship
to medical ethics
YES (7/12) 3.9 YES (8/12) 4.0
- Primacy of patient well-being in physician-patient relationship;
fiduciary obligations
- Balancing secondary gains (to finances, career, or life-work balance)
with obligations to patients
- Physicians as advocates for system change
The structure and ethical issues surrounding reimbursement systems
for physicians
YES (7/12) 3.8 YES (10/12) 4.5
- Pay for performance
- Fee for service
- Managed care and capitated payment systems
Conflicts of interest arising from physician relationships with
pharmaceutical and device industries
NO (6/12) 3.8 YES (8/12) 4.2
- Free samples as marketing
- Consulting relationships and speakers bureaus
- Sponsoring CME
The legal framework for the business of medicine YES (7/12) 3.7 YES (9/12) 4.2
- False claims act, anti-kick back statute, Stark self-referral law
- Possible penalties and sanctions
- How law influences behavior
Good stewardship in resource utilization NO (6/12) 3.6 YES (9/12) 4.2
- Exploring costs of competing treatment options
- Rationing strategies
- Value of stewardship when resources are limited
Oversight of the practice of medicine NO (5/12) 3.1 NO (6/12) 3.5
- Self-regulation vs. government regulation
- Whistleblowing—mechanics, risks, protections, responsibilities
The business relationships of academic medical centers- Influence
of educational and research mission on patient care
NO (3/12) 2.9 NO (5/12) 3.5
- Financial pressures on academic medical centers and influence on
medical practice
- Advantages and disadvantages of specific business relationships
of academic medical centers
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A majority of panelists rated 5 topics as very import-
ant or essential to teach to medical students and resi-
dents: (1) the ideals of the medical research profession;
(2) potential problems that conflicts of interest cause; (3)
strategies for managing conflicts of interest in research;
(4) challenges of playing the roles of both physician and
researcher; and (5) legal and policy issues surrounding
conflicts of interest in research. Table 2 presents these
topics rank ordered using the mean MS curriculum im-
portance score; it also presents subtopics within each of
these categories. One additional topic received a major-
ity rating of 4 or 5 for PGs: (6) valid clinical research
study design. The remaining topics received a mean rat-
ing less of than 4 for both educational groups and failed
to achieve a consensus for either group.
Discussion
The Delphi panels achieved our two aims: (a) to identify
the full range of medical business ethics topics that ex-
perts generally consider important to teach (that is, to
sketch the landscape of medical business ethics); and (b)
to establish curricular priorities through expert consen-
sus. On the one hand, Tables 1 and 2 identify a broad
range of topics, and no topic in medical research or
practice received a mean score of less than 3 (important)
for resident education. That is, both lists are comprised
of topics that are relevant to medical business ethics and
important to address prior to practicing medicine inde-
pendently. The entirety of both tables may be of value in
educating residents; shadings and rankings may help
prioritize topics when curricular time is tight. On the
other hand, Tables 1 and 2 establish curricular priorities
by identifying a top-5 list in each domain.
The project team believes that the two tables list topics
that accurately reflect the scope of the field of medical
business ethics as it is currently represented in the medical
and ethics literature and health law.
We were somewhat surprised that some topics were
not identified as curricular priorities; for example, strat-
egies for managing conflicts of interest in medical prac-
tice and the identification of institutional offices that
provide information and oversight on fiscal matters in
research. However, as noted already, no topic received a
mean score lower than 3 (important) for medical resi-
dents; thus, failure to make our “top 5” list does not in-
dicate a topic is unimportant for practicing physicians.
Table 1 Curricular priorities for business ethics in medical practice (Continued)
Disclosure rules and strategies for managing conflicts of interest NO (2/12) 2.8 NO (5/12) 3.6
- Disclosure rules such as the Physician Payments Sunshine Act and
institutional policies
- Strategies such as divestment or increased oversight
Resources physicians can consult on matters of business ethics and
compliance
NO (2/12) 2.7 NO (5/12) 3.4
- Institutional resources, including compliance officers
- External resources, including Bar Association, health lawyers, CMS
medical directors
- Educational materials, including Officer of Inspector General and
Institute of Medicine publications
Mechanics of documentation, coding, billing and audits NO (2/12) 2.6 NO (5/12) 3.6
- Accurate billing vs. upcoding
- Documentation—the need and best practices
Physician ownership of practices and facilities NO (2/12) 2.6 NO (5/12) 3.7
- Advantages and disadvantages of ownership
- Avoiding violations of self-referral and kick back laws
Conflicting interests arising from ownership vs from working as
employee or consultant
Legend:
- MS =Medical Student.
- PG = Post Graduate or Resident.
Notes:
- Consensus defined as >50% of panelists (n = 12) rated item as “very important” or “essential” (the top 2 of 5 ratings) in round 2. Results reflecting consensus
appear in boldface.
- Topics listed in rank order using the MS curriculum mean scores.
- Mean scores are based upon a 5-point Likert-type scale.
- Beneath each major topic heading above, we list the bulleted subtopics that were presented along with the overarching topics that were rated. Many subtopics
were based on topics presented in round 1; some were added by the project team prior to round 2
- Bullets indicate subtopics that were presented along with the overarching topics that were rated. Many subtopics were based on topics presented in round 1;
some were added by the project team prior to round 2.
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The ideals of the medical research profession YES (8/10) 4.3 YES (8/10) 4.2
- Pursuing new knowledge
- Developing new drugs and devices to
serve patients
- Protecting the welfare of human and
animal subjects
Potential problems that conflicts of
interest cause
YES (8/10) 4.2 YES (10/10) 4.5
- Inappropriate participant recruitment
- Biased data publication and ghost authorship
- Shifting research priorities
Strategies for managing conflicts of
interest in research
YES (8/10) 4.2 YES (9/10) 4.4
- Disclosure
- Increased oversight
- Divestment or recusal from specific roles
Challenges of playing the roles of both
physician and researcher
YES (7/10) 4.0 YES (10/10) 4.5
- Possibility of ‘therapeutic misconception’—when
patients mistake research participation for
individualized therapy
- Conflicting roles could contribute to tacit
pressure on patients to enroll or to biased
presentation of consent information
Legal and policy issues surrounding conflicts
of interest in research
YES (6/10) 3.8 YES (8/10) 4.4
- NIH conflict of interest policies
- Institutional policies
- Bayh-Dole act
Valid clinical research study design NO (5/10) 3.7 YES (6/10) 4.0
- Good research practices
- Common deviations from good research practices
Issues in academic medical research centers NO (2/10) 3.0 NO (4/10) 3.3
- Pressures to obtain grant and contract
funding
- Pressures to publish
- Balancing roles as investigator and
mentor/educator
Physician as entrepreneur, patent holder,
and owner of data and materials
NO (2/10) 2.7 NO (4/10) 3.3
- Federal and institutional rules on patents
and data ownership
- Managing conflicts of interest in ‘start up’
company research
- Managing institutional conflicts of interest
Institutional offices that provide information
and oversight on fiscal matters in research
NO (3/10) 2.7 NO (5/10) 3.3
- Office of research services (or pre-award program)
- Office of sponsored programs (or post-award program)
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More importantly, we were pleased that both panels estab-
lished as a priority exploring the fundamental goals and
ideals of the profession. While it may not be immediately ap-
parent that topics such as “the goals of medicine and their
relation to medical ethics” or “the ideals of the medical re-
search profession” directly relate to medical business ethics,
a strong commitment to the goals of medical practice and
research may do more to guide physicians in their business
practices than reminding them of specific rules, which are
granular and subject to ongoing change. Given that the
whole problem of conflicts of interest is that they provide a
motive (consciously or unconsciously) to prioritize personal
interest above the primary goals of medicine or research, ex-
ploring the significance of these goals makes good sense
[28]. As we write this, we assume that the primary goal of
medicine is patient care focused on prevention, healing, and
palliation, and that the medical relationship is a fiduciary re-
lationship in which patient interests must take priority over
other interest, such as profit, research, and education, which
are legitimate, but not primary within the context of a
patient-physician relationship [28].
We also believe it is wholly appropriate that a greater
number of topics were identified as important for med-
ical residents than medical students, given that medical
students frequently lack the relevant experience to make
the topics salient, and they are not yet “stakeholders” in
the truest sense given that they do not bill for services
and only rarely serve as principal investigators.
In undertaking this project, we have made no assump-
tions regarding where such material might best be taught.
Dealing well with business matters in medical practice is
an essential part of medical ethics and medical profession-
alism; embedding medical business ethics in such courses
or into courses on the healthcare delivery system would
make good sense. Similarly, business ethics in research
may be addressed effectively by expanding the focus of
current research ethics courses, many of which already
address conflicts of interest. However, concurrent with
the Delphi survey reported in this paper, project team
members simultaneously conducted a survey of medical
students and residents at two Mid-western schools of
medicine, which established a need for and interest in re-
ceiving training in medical business ethics [29]. In that
survey we identified strong interest in “background” issues
such as the structure of the healthcare system and reim-
bursement systems; accordingly, it may be most effect-
ive to integrate discussion of ethics cases into units
that address these larger business issues. If faculty
members are provided with discussion guides, it may
be quite feasible to integrate discussion of medical
business ethics cases into individual class sessions or
“lunch and learn” sessions with residents. In this man-
ner, we believe it is realistic to cover the 5 top-rated
topics across the 4 years of medical school or during
residency programs.
Limitations
This project has several limitations. First, our purpose
was to identify a consensus among a nonprobability
sample of experts. It cannot be assumed that the con-
sensus among our groups of 12 – 14 experts would be
identical to the consensus among a different group of
experts. Second, given the relative novelty of the area of
medical business ethics, few well-rounded experts exist.
Our panelists all represented a stakeholder group or ex-
pert group of interest; but most have narrow areas of ex-
pertise. Third, we focused on identifying curricular topics
without conducting additional Delphi rounds to identify
the level of mastery needed. We did this because the
topics are so diverse that the meaning of “basic” versus
“advanced” mastery is not constant. At one extreme,
advanced mastery of the healthcare delivery system
might require an advanced degree; at the other ex-
treme one could teach the identification of local
Table 2 Curricular priorities for business ethics in medical research (Continued)
- Conflict of interest committee
- Research integrity office
Research budgeting, costs, and billing NO (2/10) 2.5 NO (3/10) 3.0
- OMB circular A-21 rules on allowable costs
- Effort reporting and conflicts of commitment
- Accurate budget development
Legend:
- MS =Medical Student.
- PG = Post Graduate or Resident.
Notes:
- Consensus defined as >50% of panelists (n = 10) rated item as “very important” or “essential” (the top 2 of 5 ratings) in round 2. Results reflecting a consensus
appear in boldface.
- Topics listed in rank order using the MS curriculum mean scores.
- Mean scores are based upon a 5-point Likert-type scale.
- Beneath each major topic heading above, we list the bulleted subtopics that were presented along with the overarching topics that were rated. Many subtopics
were based on topics presented in round 1; some were added by the project team prior to round 2.
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resources for medical business ethics after memorizing
a 1-page handout—an “advanced” level of mastery not
much greater than “basic.”
Next steps
The Bander Center for Medical Business Ethics at Saint
Louis University has used both Delphi panels’ list of cur-
ricular priorities to develop a casebook in medical busi-
ness ethics for medical students and residents, consisting
of 14 cases followed by fact sheets, a list of relevant ethical
principles, and a presentation of relevant U.S. laws. The
casebook is indexed to the Delphi topics, and at least one
case engages each topic. The casebook and other support-
ing materials will be available online in September 2014 at
http://www.slu.edu/bander-center-home/resources. Given
the nascent state of the field of medical business ethics,
the team is committed to developing collections of rela-
tively few, high-quality materials rather than developing
comprehensive repositories of materials. We believe this will
be more useful to instructors or mentors who themselves
may lack extensive mastery of the broader subject matter.
Conclusions
Medical business ethics has attracted increasing attention
in recent years and deserves to be addressed explicitly in
undergraduate and post-graduate medical education. The
number and breadth of relevant topics can seem over-
whelming particularly in the face of limited educational
time and numerous competing curricular priorities; how-
ever, the top 5 topics identified in the domains of medical
practice and research lend themselves to exploratory
presentations using diverse formats. More importantly,
several high-priority topics might be covered in other
contexts (such as healthcare organization or patient care
quality and safety), reinforcing the point that medical busi-
ness ethics is simply a dimension of the good practice of
medicine in today’s complex healthcare system.
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